Trade Vir Biotechnology VIR

Sell
 Buy

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 May 07, 09:14

Vir Biotechnology (NASDAQ:VIR) Releases Quarterly Earnings Results, Misses Expectations By $0.84 EPS - Stock Observer

Vir Biotechnology Inc
Webhose 2026 May 07, 08:18

Vir Biotechnology Q1 Earnings Call Highlights

Vir Biotechnology Inc
Webhose 2026 May 07, 05:44

Insider Selling: Vir Biotechnology (NASDAQ:VIR) Director Sells $221,100.00 in Stock - Stock Observer

Vir Biotechnology Inc
Webhose 2026 May 06, 02:04

Vicki Sato Sells 22,000 Shares of Vir Biotechnology (NASDAQ:VIR) Stock - Daily Political

Vir Biotechnology Inc
Webhose 2026 May 05, 06:19

How Insider Sale and VIR-5500 Milestone at Vir Biotechnology (VIR) Have Changed Its Investment Story

Vir Biotechnology Inc
Webhose 2026 May 04, 18:52

Vir Biotechnology (NASDAQ:VIR) Director Vicki Sato Sells 22,000 Shares

Vir Biotechnology Inc
Webhose 2026 May 04, 12:04

Vir Biotechnology (VIR) Projected to Post Quarterly Earnings on Wednesday - Zolmax

Vir Biotechnology Inc
Webhose 2026 Apr 29, 11:49

Vir Biotechnology (VIR) Expected to Announce Quarterly Earnings on Wednesday

Vir Biotechnology Inc
Webhose 2026 Apr 28, 03:16

Assessing Vir Biotechnology (VIR) Valuation After Recent Share Price Momentum

Vir Biotechnology Inc
Webhose 2026 Apr 26, 19:43

Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?

Vir Biotechnology Inc
Webhose 2026 Apr 22, 14:27

Vir Biotechnology (VIR) Posts 80.98% Year-To-Date Growth

Vir Biotechnology Inc
Webhose 2026 Apr 21, 18:19

10 Best Small-Cap Biotech Stocks According to Hedge Funds

Vir Biotechnology Inc
Webhose 2026 Apr 21, 13:09

Vir Biotechnology (VIR) Is Up 19.1% After Astellas Cancer Pact Closes With $315M Inflows

Vir Biotechnology Inc
Webhose 2026 Apr 20, 14:47

Can Vir Biotechnology (VIR)'s Masked T-Cell Technology Crack the Hardest-to-Treat Prostate Cancer?

Vir Biotechnology Inc
Webhose 2026 Apr 20, 13:58

Vir Biotechnology (NASDAQ:VIR) Sets New 1-Year High - Here's Why - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Apr 20, 00:11

Is Vir Biotechnology (VIR) One of the Best Low Priced Biotech Stocks to Invest In?

Vir Biotechnology Inc
Webhose 2026 Apr 16, 22:15

Vir Biotechnology (VIR) Valuation After Astellas Partnership And New VIR 5500 Trial Milestone

Vir Biotechnology Inc
Webhose 2026 Apr 16, 12:05

Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer | Morningstar

Vir Biotechnology Inc
Webhose 2026 Apr 13, 14:05

Phase 1 trial designed to assess the safety, pharmacokinetic

Vir Biotechnology Inc
Webhose 2026 Apr 13, 07:45

Brokerages Set Vir Biotechnology, Inc. (NASDAQ:VIR) PT at $20.44

Vir Biotechnology Inc
Webhose 2026 Apr 12, 09:21

Should Vir's CMO Exit and Astellas Funding Boost Reshape How Investors View Its R&D Strategy (VIR)?

Vir Biotechnology Inc
Webhose 2026 Apr 10, 13:51

Vir Biotechnology (VIR) Leading with Its BiTEs Therapy

Vir Biotechnology Inc
Webhose 2026 Apr 09, 07:02

Aberdeen Group plc Sells 135,688 Shares of Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc

VirBiotechnology news

number1 2025 Jul 11, 03:38

AI Podcast: Dollar Weakness and Investment Implications

number1 2025 Jul 11, 03:38

HSBC: Three 'Painful Trade' Risks Loom if Wall Street Gets It Wrong

number1 2025 Jul 11, 03:38

Turkey's $500 Billion Gold Hoard: Unlocking Economic Potential

number1 2025 Jul 11, 03:37

Brazil-US Tariffs: Trump's Intervention and Lula's Response

number1 2025 Jul 11, 00:00

AI Podcast: US & Israel's Disagreements on Iran and Gaza

Latest news

Show more
number1 2025 Oct 21, 00:00

Zelenskyy Expresses Doubts About Budapest as Venue for Ukraine Peace Talks

number1 2025 Oct 21, 00:00

Europe Rallies Behind Ukraine Amid Trump Pressure, Eyes Frozen Russian Assets

number1 2025 Oct 21, 00:00

US Government Shutdown: Economic Fallout and Political Impasse

number1 2025 Oct 21, 00:00

Gold Price Surge Fueled by Fed Rate Cut Expectations and Economic Uncertainty

number1 2025 Oct 19, 00:00

Global Market Overview: Precious Metals Surge Amidst Economic Uncertainty

number1 2025 Oct 18, 00:00

Japan LDP-Ishin Policy Talks: Paving the Way for a New Prime Minister?

number1 2025 Oct 18, 00:00

Israel Prepares to Reopen Rafah Crossing Amid Ceasefire Violation Claims

number1 2025 Oct 18, 00:00

Fed's Rate Cut Conundrum: An Outlook to 2026

Info

Spread

0.11

Spread (%)

1.2182 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

13:31 - 19:59

Monday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1563403776

Shares Outstanding

168651974

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.13

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

latest_education_articles

Show more
Frances Wang 2025 Feb 17, 16:00

Pi network price prediction 2025: Will Pi Network price go up or down?

Stocks
Frances Wang 2025 Jan 21, 16:00

What is the XRP price prediction for 2025: Will XRP reach $1000?

Crypto
Frances Wang 2024 Dec 29, 16:00

What is the USD DXY index and how does the DXY reflect the dollar's value?

Indices
Trustpilot